LEVETIRACETAM DEXCEL 500

Země: Izrael

Jazyk: angličtina

Zdroj: Ministry of Health

Aktivní složka:

LEVETIRACETAM

Dostupné s:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC kód:

N03AX14

Léková forma:

TABLETS

Složení:

LEVETIRACETAM 500 MG

Podání:

PER OS

Druh předpisu:

Required

Výrobce:

DEXCEL LTD, ISRAEL

Terapeutické skupiny:

LEVETIRACETAM

Terapeutické oblasti:

LEVETIRACETAM

Terapeutické indikace:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Datum autorizace:

2018-03-31